[Minimally invasive video-assisted parathyroidectomy (MIVAP) using primary hyperparathyroidism therapy (pHPT)]

Area of Science:

• Endocrine Surgery
• Minimally Invasive Surgery
• Parathyroid Disease Management

Background:

• Primary hyperparathyroidism (pHPT) is a metabolic disorder characterized by excessive parathyroid hormone secretion.
• Surgical parathyroidectomy is the definitive treatment for pHPT.
• Advancements in surgical techniques aim to improve outcomes and reduce invasiveness.

Purpose of the Study:

• To evaluate the efficacy and outcomes of Minimally Invasive Video-Assisted Parathyroidectomy (MIVAP) for primary hyperparathyroidism.
• To assess the success rates and complication profiles of MIVAP compared to traditional methods.
• To determine the suitability of MIVAP for parathyroid adenoma removal.

Main Methods:

• Retrospective study of patients undergoing parathyroid surgery between 2005 and 2011.
• Analysis of 182 patients with hyperparathyroidism, focusing on 82 who underwent MIVAP.
• Comparison of MIVAP outcomes with standard parathyroidectomy and Minimally Invasive Radio-Guided Parathyroidectomy (MIRP).

Main Results:

• MIVAP was performed on 82 patients, with parathyroid adenoma being the most common diagnosis (95.1%).
• The MIVAP technique achieved an 87.8% success rate in removing parathyroid adenomas, with an additional 6 adenomas removed during conversion.
• No permanent recurrent laryngeal nerve (RLN) paresis was observed; temporary paresis occurred in 4.9% of patients.

Conclusions:

• Minimally Invasive Video-Assisted Parathyroidectomy (MIVAP) is a complex endoscopic technique with a high success rate (approximately 90%) for treating primary hyperparathyroidism.
• MIVAP is particularly effective when the parathyroid adenoma is accurately located using ultrasound and MIBI scanning.
• The technique offers a viable minimally invasive option for parathyroid adenoma removal with a low complication rate.